By comparison, combination formulations (lutein plus zeaxanthin or epilutein) showed a significant benefit for MPOD (Hedges’ g = −0.551; p = 0.029), whereas the effect on BCVA did not reach statistical significance (Hedges’ g = −0.484; p = 0.291) (Supporting Figure S1 ). 3.4.
← all excerpts
From Supplements to Sight: Quantifying the Impact of Lutein and Carotenoid on Age-Related Macular Degeneration-A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
1
0.2910
0.2910